Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Lytus Technologies Holdings PTV. Ltd. Common Shares (LYT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: LYT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -68.16% | Avg. Invested days 12 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 9.93M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 73284924 | Beta 2.22 | 52 Weeks Range 0.01 - 5.00 | Updated Date 04/2/2025 |
52 Weeks Range 0.01 - 5.00 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 119.22 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 9.51% | Operating Margin (TTM) 6.11% |
Management Effectiveness
Return on Assets (TTM) 2.47% | Return on Equity (TTM) 17.28% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1605720 | Price to Sales(TTM) 0.42 |
Enterprise Value 1605720 | Price to Sales(TTM) 0.42 | ||
Enterprise Value to Revenue 0.07 | Enterprise Value to EBITDA 0.43 | Shares Outstanding 31111000 | Shares Floating 4933622 |
Shares Outstanding 31111000 | Shares Floating 4933622 | ||
Percent Insiders 4 | Percent Institutions 0.18 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Lytus Technologies Holdings PTV. Ltd. Common Shares
Company Overview
History and Background
Lytus Technologies Holdings PTV. Ltd. is a company focusing on telehealth and e-pharmacy solutions. Specific founding year and detailed milestones are not readily available in common financial databases. It appears to be relatively new to the public markets.
Core Business Areas
- Telehealth: Provides remote healthcare services, including virtual consultations, remote patient monitoring, and chronic disease management.
- E-pharmacy: Offers online pharmacy services, enabling patients to order prescription and over-the-counter medications online.
- Healthcare Technology: Develops and implements various technologies to support remote healthcare like the data processing platform and the on-demand distribution system.
Leadership and Structure
Information on the detailed leadership team and organizational structure is not easily accessible. Publicly available information is limited.
Top Products and Market Share
Key Offerings
- Virtual Consultations: Allows patients to consult with healthcare professionals remotely. Market share data specific to Lytus is unavailable. Competitors include Teladoc Health (TDOC) and Amwell (AMWL).
- Online Pharmacy Services: Enables patients to purchase medications online. Market share data specific to Lytus is unavailable. Competitors include Capsule and Amazon Pharmacy (AMZN).
Market Dynamics
Industry Overview
The telehealth and e-pharmacy industries are experiencing rapid growth, driven by increasing demand for convenient and accessible healthcare services and greater Internet adoption. The market is fragmented with both large and small players.
Positioning
Lytus Technologies is positioned as a provider of telehealth and e-pharmacy solutions. Their competitive advantage would depend on factors such as service quality, technology integration, and pricing.
Total Addressable Market (TAM)
The telehealth market is projected to reach hundreds of billions of dollars within the next few years. Lytus is relatively small and positioned to capture a small portion of this TAM. E-pharmacy is projected to grow to over $175 Billion.
Upturn SWOT Analysis
Strengths
- Focus on growing telehealth and e-pharmacy markets
- Potential for scalability through technology
- Opportunity to serve underserved populations
Weaknesses
- Limited brand recognition and market share
- Dependence on regulatory approvals
- Financial constraints typical of smaller companies
Opportunities
- Partnerships with healthcare providers and insurers
- Expansion into new geographic markets
- Development of innovative telehealth solutions
Threats
- Increased competition from established players
- Changes in regulations affecting telehealth and e-pharmacy
- Data security and privacy concerns
Competitors and Market Share
Key Competitors
- TDOC
- AMZN
- AMWL
- CVS
- WBA
Competitive Landscape
Lytus Technologies faces stiff competition from established players with greater resources and brand recognition. It needs to differentiate itself through innovation or niche market focus.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Limited historical data available.
Future Projections: Future projections are difficult to assess without comprehensive financial data and analyst coverage.
Recent Initiatives: Unavailable. Information is limited.
Summary
Lytus Technologies is a small company in the telehealth and e-pharmacy market with limited data available. It faces significant competition and needs to execute well to achieve growth. Its future success depends on strategic partnerships, regulatory environment, and technological innovation. Due to the limited access to information this company is hard to fully asses.
Similar Companies
AMWL
American Well Corp
AMWL
American Well Corp
CVS
CVS Health Corp
CVS
CVS Health Corp
TDOC
Teladoc Inc
TDOC
Teladoc Inc
WBA
Walgreens Boots Alliance Inc
WBA
Walgreens Boots Alliance Inc
Sources and Disclaimers
Data Sources:
- Yahoo Finance
- Company press releases
- Industry reports
Disclaimers:
The information provided is based on limited publicly available data. Market share data is estimated. This analysis is not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Lytus Technologies Holdings PTV. Ltd. Common Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2022-06-15 | Global CEO, MD & Director Mr. Dharmesh Pandya | ||
Sector Technology | Industry Software - Application | Full time employees - | Website https://www.lytuscorp.com |
Full time employees - | Website https://www.lytuscorp.com | ||
Lytus Technologies Holdings PTV. Ltd. operates as a platform services company in India. It operates in two segments, Cable Services and Telemedicine Services. The company engages in the distribution of linear content streaming/telecasting services; and development of telemedicine and fintech products. Lytus Technologies Holdings PTV. Ltd. was incorporated in 2020 and is based in Mumbai, India.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.